InterviewsDecember 18, 2020 Back of the Yard Algae Sciences: Toward the First Vertically Integrated Psychedelic Producer
PressDecember 18, 2020 MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand
Psychedelic NewsDecember 17, 2020 A New Fund Dedicated to Psychedelic Investments Has Launched in the UK
PressDecember 16, 2020 Ehave, Inc. Announces KetaDASH for Ketamine Home Delivery and Purchase of Curedash Assets
PressDecember 15, 2020 PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders
Psychedelic NewsDecember 15, 2020 Christian Angermayer: ‘This Will be the Best Performing Asset Class Over the Next 20 Years’
PressDecember 14, 2020 Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note
PressDecember 11, 2020 MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)
InterviewsDecember 11, 2020 Greenway DNA: Leveraging DNA to Solve the Dosing Challenge in Natural Medicine
PressDecember 11, 2020 Better Plant Subsidiary NeonMind Announces Filing of Final Prospectus in Connection with an Initial Public Offering
PressDecember 10, 2020 Tryp Therapeutics Files Final Prospectus and Announces Initial Public Offering
PressDecember 9, 2020 Red Light Holland Announces Intention to Acquire Controlling Interest in Psychedelic Insights Providing Psychological Guidance of Psychedelic Experiences with Truffles in the Netherlands
PressDecember 9, 2020 Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs Inc. Completion of Initial DMT Research Drug Batch
PressDecember 8, 2020 17 Canadian Healthcare Professionals Approved to Use Psilocybin for Professional Training – TheraPsil
PressDecember 8, 2020 Champignon Brands Appoints Christopher Hobbs as Interim Chief Financial Officer
PressDecember 8, 2020 Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms
PressDecember 7, 2020 CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth
